Form 4: Medpace Holdings Director Acquires Stock Options

Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., acquired stock options exercisable for 1,224 shares of common stock.

Summary

• On May 16, 2025, Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., acquired stock options.
• The options grant the right to buy 1,224 shares of Medpace Holdings common stock at an exercise price of $305.66.
• The options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• The options expire on May 16, 2032.
• Following the transaction, McCarthy directly owns 1,224 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock option grant to a director. While option grants can be seen as positive incentives, the document itself is simply a factual reporting of the transaction.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company directors and officers.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's increased stake in the company's success.

Key Dates

Keywords

Medpace Holdings, Director, Stock Options, Form 4, Beneficial Ownership, MEDP, McCarthy, Insider Trading